Amundi’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$749K Buy
33,437
+10,572
+46% +$276K ﹤0.01% 1490
2026
Q1
$626K Buy
22,865
+9,744
+74% +$346K ﹤0.01% 1460
2025
Q4
$546K Buy
13,121
+571
+5% +$23.2K ﹤0.01% 1438
2025
Q3
$597K Hold
12,550
﹤0.01% 1280
2025
Q2
$713K Buy
12,550
+48
+0.4% +$2.54K ﹤0.01% 1278
2025
Q1
$630K Hold
12,502
﹤0.01% 1444
2024
Q4
$570K Sell
12,502
-33,826
-73% -$1.5M ﹤0.01% 1542
2024
Q3
$2.26M Buy
46,328
+2,965
+7% +$199K ﹤0.01% 1127
2024
Q2
$2.86M Sell
43,363
-65,443
-60% -$3.93M ﹤0.01% 1047
2024
Q1
$5.96M Buy
108,806
+77,062
+243% +$6.26M ﹤0.01% 935
2023
Q4
$3.06M Sell
31,744
-5,134
-14% -$447K ﹤0.01% 1092
2023
Q3
$2.92M Buy
36,878
+9,485
+35% +$744K ﹤0.01% 1091
2023
Q2
$2.28M Buy
27,393
+27,367
+105,258% +$2.56M ﹤0.01% 1136
2023
Q1
$2.94K Sell
26
-11,964
-100% -$1.62M ﹤0.01% 2034
2022
Q4
$1.67M Buy
11,990
+11,964
+46,015% +$1.45M ﹤0.01% 1222
2022
Q3
$3K Sell
26
-347
-93% -$44.4K ﹤0.01% 1814
2022
Q2
$47K Buy
373
+108
+41% +$16.3K ﹤0.01% 1544
2022
Q1
$41K Buy
+265
New +$50.3K ﹤0.01% 1551

Other funds holding CNXC

Amundi's CNXC Position: Q2 2026 in Review

Amundi increased its Concentrix (CNXC) stake by 46% in Q2 2026, buying an estimated $276K and bringing the position to 33,437 shares worth $749K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Amundi first reported a position in CNXC in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.96M in Q1 2024. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Amundi held 33,437 shares of Concentrix worth $749K as of Q2 2026.
  • Amundi bought 10,572 Concentrix shares in Q2 2026, an estimated $276K.
  • Concentrix made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1490 holding.
  • Amundi first reported a position in Concentrix in Q1 2022 and has held it in 18 quarters since.
  • Amundi's Concentrix position peaked at $5.96M in Q1 2024.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.